Evotec AG ADR | |
Stock Exchange | Other OTC |
EPS |
$1.45 |
Market Cap |
$4.32 B |
Shares Outstanding |
74.95 M |
Public Float |
92.24 M |
Evotec AG | |
Stock Exchange | Xetra Stock Exchange |
EPS |
EUR0.63 |
Market Cap |
EUR3.84 B |
Shares Outstanding |
149.9 M |
Public Float |
120.33 M |
Evotec AG | |
Stock Exchange | SIX Swiss Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
147.53 M |
Public Float |
- |
Address |
Manfred Eigen Campus Hamburg Hamburg 22419 Germany |
Employees | - |
Website | http://evotec.com |
Updated | 07/08/2019 |
Evotec AG engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the EVT Execute and EVT Innovate segments. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmes on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. |